Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
The Monthly: September 2021
02 Sep 2021
MORhomes
Investment Companies
Sustainable bond framework and earnings
By
Mark Thomas
24 Aug 2021
Stay up-to-date with the latest research
Sign up to our newsletter
Shield Therapeutics Plc
Life Sciences
Focused on US market penetration
By
Dr Martin Hall
20 Aug 2021
Sportech Plc
Consumer
Cash payout
By
Jason Streets
19 Aug 2021
Pantheon International Plc
Financials
FY’21: 20% NAV growth; right place at right time
19 Aug 2021
Arbuthnot Banking Group Plc
Financials
1H’21 results: a return to profitable growth
By
Mark Thomas
18 Aug 2021
CyanConnode
Technology
FY’21 results; revisiting addressable markets
By
Milan Radia
17 Aug 2021
Advanced Oncotherapy
Life Sciences
Funded to completion
By
Dr Martin Hall
12 Aug 2021
Real Estate Credit Investments (RECI)
Investment Companies
Experience shows resilience of the model (2)
By
Mark Thomas
12 Aug 2021
Good jobs come to those who IPO: The importance of going public
By
Keith Hiscock
06 Aug 2021
CyanConnode
Technology
Major new contracts in India and Africa
By
Milan Radia
05 Aug 2021
Prev
1
...
22
23
24
25
26
...
75
Next